|
SLC7A6OS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.22639999999786E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.676400E-02 |
| Normal-vs-Stage2 |
5.640400E-02 |
| Normal-vs-Stage3 |
5.456100E-02 |
| Normal-vs-Stage4 |
8.836600E-01 |
| Stage1-vs-Stage2 |
3.883400E-01 |
| Stage1-vs-Stage3 |
4.324800E-01 |
| Stage1-vs-Stage4 |
3.403200E-01 |
| Stage2-vs-Stage3 |
8.957600E-01 |
| Stage2-vs-Stage4 |
1.631820E-01 |
| Stage3-vs-Stage4 |
2.081800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.359030E-04 |
| Normal-vs-AfricanAmerican |
1.019370E-01 |
| Normal-vs-Asian |
2.701200E-01 |
| Caucasian-vs-AfricanAmerican |
2.705600E-01 |
| Caucasian-vs-Asian |
6.534400E-01 |
| AfricanAmerican-vs-Asian |
3.846800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.367300E-04 |
| Normal-vs-Female |
2.324400E-03 |
| Male-vs-Female |
5.408400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.960600E-01 |
| Normal-vs-Extreme_Weight |
3.893700E-02 |
| Normal-vs-Obese |
3.017100E-03 |
| Normal-vs-Extreme_Obese |
5.011000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.335570E-01 |
| Normal_Weight-vs-Obese |
2.110300E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.204000E-01 |
| Extreme_Weight-vs-Obese |
2.552800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.784200E-01 |
| Obese-vs-Extreme_Obese |
6.119800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.068950E-01 |
| Normal-vs-Age(41-60Yrs) |
2.586400E-04 |
| Normal-vs-Age(61-80Yrs) |
2.902300E-03 |
| Normal-vs-Age(81-100Yrs) |
5.869000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.693000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.586600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.961600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.185000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.879400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.922390E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.594780E-04 |
| Normal-VS-Type2 PRCC |
8.384400E-02 |
| Normal-VS-KIRP CIMP |
2.388200E-01 |
| Normal-VS-Unclassified PRCC |
7.215900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.195200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.175400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.015900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.564000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.219700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.208000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.420560E-01 |
| Normal-vs-N1 |
1.210200E-01 |
| Normal-vs-N2 |
6.229800E-01 |
| N0-vs-N1 |
9.128600E-01 |
| N0-vs-N2 |
4.015200E-01 |
| N1-vs-N2 |
2.500800E-01 |
|
|
